Related Experiment Video
Updated: Jul 13, 2026
09:03
Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
Published on: March 17, 2023
Infrastructure development for human cell therapy translation.
A B Dietz1, D J Padley, D A Gastineau
1Human Cellular Therapy Laboratory, Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. Dietz.Allan@mayo.edu
Clinical Pharmacology and Therapeutics
|July 20, 2007
Summary
Cell therapy utilizes cells as medicinal products, building on decades of use. Establishing robust infrastructure and quality control is crucial for the safe and effective development of these cellular therapies in clinical trials.
Area of Science:
- Cellular therapy
- Biotechnology
- Regenerative medicine
Background:
- Cells have historically been used therapeutically, with early examples including tissue transplantation like bone marrow.
- The concept of cells as drugs has evolved, with a growing focus on their specific therapeutic effects.
Purpose of the Study:
- To explore the regulatory landscape and practical design considerations for manufacturing infrastructure supporting cell therapy development.
- To highlight the critical role of infrastructure in ensuring the safety, potency, and regulatory compliance of cell therapy products, especially for early clinical trials.
Main Methods:
- Review of historical cell transplantation practices and lessons learned from blood banking.
- Analysis of the regulatory environment impacting cell therapy manufacturing.
- Discussion of practical design considerations for manufacturing facilities.
Main Results:
- Quality control, process control, sterility, and product tracking are essential for cell therapy safety and potency, drawing parallels with blood banking.
- Development of specialized infrastructure is necessary to support the increasing exploitation of cells as drugs.
- Facility design must consider capital investment and its role in regulatory compliance.
Conclusions:
- Cellular therapies represent a critical advancement in medicine, requiring specialized infrastructure and stringent quality control.
- The successful translation of cell therapies from research to clinical application hinges on careful planning of manufacturing facilities and adherence to regulatory guidelines.
